A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi-Reference-Cited by-同舟云学术

A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi

Published:2015-05-07 Issue:5 Volume:11 Page:e1004828
ISSN:1553-7374
Container-title:PLOS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Gupta Shivali,Garg Nisha J.

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference61 articles.

1. World Health Organization (2010) Chagas disease: control and elimination. UNDP/World Bank/WHO. http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_17-en.pdf, accessed on Mar 5, 2015.

2. Chagas disease cardiomyopathy: immunopathology and genetics;E Cunha-Neto;Mediators Inflamm,2014

3. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors;PT Cantey;Transfusion,2012

4. Trypanosoma cruzi and Chagas' Disease in the United States;C Bern;Clin Microbiol Rev,2011

5. An estimate of the burden of Chagas disease in the United States;C Bern;Clin Infect Dis,2009

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunization with a Trypanosoma cruzi cyclophilin-19 deletion mutant protects against acute Chagas disease in mice;npj Vaccines;2023-04-25

2. Protective immunity triggered by ectonucleoside triphosphate diphosphohydrolase-based biopharmaceuticals attenuates cardiac parasitism and prevents mortality in Trypanosoma cruzi infection;Bioorganic & Medicinal Chemistry;2022-10

3. Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions;The Lancet Microbe;2022-09

4. Vaccine Design against Chagas Disease Focused on the Use of Nucleic Acids;Vaccines;2022-04-12

5. Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease;npj Vaccines;2021-09-08